Blue Trust Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.36K Hold
20
﹤0.01% 2107
2025
Q4
$3.28K Hold
20
﹤0.01% 2065
2025
Q3
$2.67K Hold
20
﹤0.01% 2106
2025
Q2
$2.49K Hold
20
﹤0.01% 2106
2025
Q1
$2.54K Buy
+20
New +$3.08K ﹤0.01% 2198
2024
Q4
Sell
-239
Closed -$30.1K 2872
2024
Q3
$30.1K Buy
239
+127
+113% +$18.2K ﹤0.01% 1782
2024
Q2
$20.6K Buy
112
+41
+58% +$6.43K ﹤0.01% 1646
2024
Q1
$13.1K Buy
71
+1
+1% +$190 ﹤0.01% 1375
2023
Q4
$11K Sell
70
-41
-37% -$6.38K ﹤0.01% 1557
2023
Q3
$16K Buy
111
+37
+50% +$6.05K ﹤0.01% 1252
2023
Q2
$12K Sell
74
-67
-48% -$10.7K ﹤0.01% 1248
2023
Q1
$24K Buy
141
+46
+48% +$8.21K ﹤0.01% 1309
2022
Q4
$18K Buy
95
+38
+67% +$6.89K ﹤0.01% 1329
2022
Q3
$9K Buy
57
+36
+171% +$7.59K ﹤0.01% 1386
2022
Q2
$4K Buy
+21
New +$3.32K ﹤0.01% 1519

Other funds holding RGEN

Blue Trust Inc's RGEN Position: Q1 2026 in Review

Blue Trust Inc held its Repligen (RGEN) position steady in Q1 2026 at 20 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Blue Trust Inc first reported a position in RGEN in Q2 2022 and has held it in 15 quarters since. The position peaked at $30.1K in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Blue Trust Inc held 20 shares of Repligen worth $2.36K as of Q1 2026.
  • Blue Trust Inc left its Repligen share count unchanged in Q1 2026.
  • Repligen made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #2107 holding.
  • Blue Trust Inc first reported a position in Repligen in Q2 2022 and has held it in 15 quarters since.
  • Blue Trust Inc's Repligen position peaked at $30.1K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.